In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles

Research output: Contribution to journalArticlepeer-review


  • M.V.D.Z. Park
  • W. Annema
  • A.H. Piersma
  • W.H. de Jong
  • A. Salvati
  • A. Lesniak
  • K.A. Dawson
  • A. Elsaesser
  • C. Barnes
  • G. McKerr
  • C.V. Howard

Colleges, School and Institutes

External organisations

  • National Institute for Public Health and the Environment (RIVM)
  • Utrecht University


While research into the potential toxic properties of nanomaterials is now increasing, the area of developmental toxicity has remained relatively uninvestigated. The embryonic stem cell test is an in vitro screening assay used to investigate the embryotoxic potential of chemicals by determining their ability to inhibit differentiation of embryonic stem cells into spontaneously contracting cardiomyocytes. Four well characterized silica nanoparticles of various sizes were used to investigate whether nanomaterials are capable of inhibition of differentiation in the embryonic stem cell test. Nanoparticle size distributions and dispersion characteristics were determined before and during incubation in the stem cell culture medium by means of transmission electron microscopy (TEM) and dynamic light scattering. Mouse embryonic stem cells were exposed to silica nanoparticles at concentrations ranging from 1 to 100 μg/ml. The embryonic stem cell test detected a concentration dependent inhibition of differentiation of stem cells into contracting cardiomyocytes by two silica nanoparticles of primary size 10 (TEM 11) and 30 (TEM 34) nm while two other particles of primary size 80 (TEM 34) and 400 (TEM 248) nm had no effect up to the highest concentration tested. Inhibition of differentiation of stem cells occurred below cytotoxic concentrations, indicating a specific effect of the particles on the differentiation of the embryonic stem cells. The impaired differentiation of stem cells by such widely used particles warrants further investigation into the potential of these nanoparticles to migrate into the uterus, placenta and embryo and their possible effects on embryogenesis.

Bibliographic note

MEDLINE® is the source for the MeSH terms of this document.


Original languageEnglish
Pages (from-to)108-116
Number of pages9
JournalToxicology and applied pharmacology
Issue number1
Publication statusPublished - 1 Oct 2009